Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$244.93 - $354.82 $465,856 - $674,867
-1,902 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$295.56 - $354.83 $34,580 - $41,515
-117 Reduced 5.79%
1,902 $674,000
Q4 2021

Feb 14, 2022

BUY
$289.48 - $383.27 $195,399 - $258,707
675 Added 50.22%
2,019 $663,000
Q3 2021

Nov 12, 2021

SELL
$360.3 - $422.82 $151,686 - $178,007
-421 Reduced 23.85%
1,344 $506,000
Q2 2021

Aug 13, 2021

BUY
$385.96 - $443.85 $273,259 - $314,245
708 Added 66.98%
1,765 $709,000
Q1 2021

May 14, 2021

SELL
$372.25 - $429.44 $15,634 - $18,036
-42 Reduced 3.82%
1,057 $439,000
Q4 2020

Feb 08, 2021

BUY
$318.23 - $411.57 $4,455 - $5,761
14 Added 1.29%
1,099 $452,000
Q3 2020

Nov 12, 2020

SELL
$326.7 - $408.18 $16,661 - $20,817
-51 Reduced 4.49%
1,085 $369,000
Q2 2020

Jul 17, 2020

BUY
$279.8 - $376.58 $45,327 - $61,005
162 Added 16.63%
1,136 $413,000
Q1 2020

May 12, 2020

BUY
$225.31 - $395.14 $219,451 - $384,866
974 New
974 $285,000

Others Institutions Holding TFX

About TELEFLEX INC


  • Ticker TFX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,906,400
  • Market Cap $8.36B
  • Description
  • Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...
More about TFX
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.